Cargando…
Trametinib: Could It Be a Promising Drug to Treat Atypical Chronic Myeloid Leukemia?
Atypical chronic myeloid leukemia (aCML) is a rare disease that is currently classified under the myelodysplastic (MDS)/myeloproliferative neoplasm (MPN) disease spectrum. MDS/MPN diseases are characterized by the absence of the Philadelphia (Ph) chromosome and the overlap between bone marrow fibros...
Autores principales: | Elsayed, Marwa, Harry, Stephanie, Nanua, Suprana, Zaidi, Shayaan, Habib, Muhammad H, Raza, Shahzad |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9356656/ https://www.ncbi.nlm.nih.gov/pubmed/35949766 http://dx.doi.org/10.7759/cureus.26619 |
Ejemplares similares
-
Recognizing acute promyelocytic leukemia in a patient with treated chronic lymphocytic leukemia
por: Nanua, Suparna, et al.
Publicado: (2020) -
Molecular Pathogenesis of BCR-ABL-Negative Atypical Chronic Myeloid Leukemia
por: Fontana, Diletta, et al.
Publicado: (2021) -
Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis
por: Guarnera, Luca, et al.
Publicado: (2022) -
Atypical presentation of patients with chronic myeloid leukemia in chronic phase—Case report
por: Ramdohr, Florian, et al.
Publicado: (2022) -
Lysine-Specific Demethylase 1A as a Promising Target in Acute Myeloid Leukemia
por: Magliulo, Daniela, et al.
Publicado: (2018)